Abstract
Infertility is a common medical condition that affects up to 15% of couples. In addition to the wide range of potential etiologies, infertility is complex in ways unique within Obstetrics and Gynecology given its involvement of both the patient and her partner as well as the variable insurance coverage and access to resources. The diagnosis of infertility, alongside the evaluation and treatment, can be an emotionally challenging and uniquely difficult time for patients and their partners alike; often impacting their quality of life and relationship. Importantly, with the delays in child-bearing in our society, the impact of a woman’s age and the biological clock are playing a critical role. Fortunately, with advances in diagnostic and therapeutic maneuvers including assisted reproductive technologies, there are many options that can maximize a woman’s chances for building a family. This chapter outlines the initial evaluation of a patient with infertility including the most common etiologies, the diagnostic work-up, and current and evolving treatment options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- Infertility:
-
Defined as 1 year of unprotected intercourse without successful conception
- Ovarian reserve:
-
Refers to the number and quality of remaining oocytes
- Anti-Müllerian Hormone (AMH):
-
Is produced by the granulosa cells of ovarian follicles and reflects the primordial follicle reserve
- Antral Follicle count (AFC):
-
A method of assessing ovarian reserve that utilizes transvaginal ultrasound in the early follicular phase to quantify the number of follicles between 2 and 10 mm in diameter
- Hysterosalpingography (HSG):
-
Is a radiographic evaluation of the uterine cavity and fallopian tubes
References
Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008;89(6):1603.
Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril. 1991;56(2):192–3.
Greenhall E, Vessey M. The prevalence of subfertility: a review of the current confusion and a report of two new studies. Fertil Steril. 1990;54(6):978–83.
FastStats [Internet]. Cdc.gov. 2016 [cited 7 April 2016]. Available from: ► http://www.cdc.gov/nchs/fastats/infertility.htm.
Assisted reproductive technology success rates [Internet]. 1st ed. Atlanta: Centers for Disease Control and Prevention; 2013 [cited 8 April 2016]. Available from: ► http://www.cdc.gov/art/pdf/2013-report/art_2013_national_summary_report.pdf
Maroulis G. Effect of Aging on Fertility and Pregnancy. Semin Reprod Med. 1991;9(03):165–75.
Treloar AE. Menarche, menopause, and intervening fecundability. Hum Biol. 1974;89-107
Henry L, Caldwell JC, Higgins M, Williamson JG. Some data on natural fertility. Eugen Q. 1967;8(2):81–91.
Stein ZA. A woman’s age: childbearing and child rearing. Am J Epidemiol. 1985;121(3):327–42.
Mosher WD. Infertility trends among US couples: 1965-1976. Fam Plan Perspect. 1982;14(1):22–7.
Hamilton BE, Sutton PD, Ventura SJ. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Stat Rep. 2003;51(12):n12.
ten Broek RP, Issa Y, van Santbrink EJ, Bouvy ND, Kruitwagen RF, Jeekel J, et al. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ. 2013;347:f5588.
Deans R, Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010;17(5):555–69.
Tam WH, Lau WC, Cheung LP, Yuen PM, Chung TK. Intrauterine adhesions after conservative and surgical management of spontaneous abortion. J Am Assoc Gynecol Laparosc. 2002;9(2):182–5.
Preconception Carrier Screening FAQ [Internet]. 1st ed. ACOG; 2012 [cited 7 April 2016]. Available from: ► http://www.acog.org/~/media/For%20Patients/faq179.pdf
Frishman GN, Spurrell TP, Heber WW. Folic acid. Preconception knowledge and use by infertile women. J Reprod Med. 2001;46(12):1025–30.
Kaye AD, Clarke RC, Sabar R, Vig S, Dhawan KP, Hofbauer R, Kaye AM. Herbal medicines: current trends in anesthesiology practice—a hospital survey. J Clin Anesth. 2000;12(6):468–71.
Gordon CM. Functional hypothalamic amenorrhea. N Engl J Med. 2010;363(4):365–71.
Olive DL. Exercise and fertility: an update. Curr Opin Obstet Gynecol. 2010;22(4):259–63.
George L, Granath F, Johansson AL, Annerén G, Cnattingius S. Environmental tobacco smoke and risk of spontaneous abortion. Epidemiology. 2006;17(5):500–5.
Roth LK, Taylor HS. Risks of smoking to reproductive health: assessment of women’s knowledge. Am J Obstet Gynecol. 2001;184(5):934–9.
Stillman RJ. Seminar in reproductive endocrinology: smoking and reproductive health. New York: Thieme Medical Publishers; 1989.
Laurent SL, Thompson SJ, Addy C, Garrison CZ, Moore EE. An epidemiologic study of smoking and primary infertility in women. Fertil Steril. 1992;57(3):565–72.
Künzle R, Mueller MD, Hänggi W, Birkhäuser MH, Drescher H, Bersinger NA. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril. 2003;79(2):287–91.
Williams M, Hill CJ, Scudamore I, Dunphy B, Cooke ID, Barratt CL. Physiology: sperm numbers and distribution within the human fallopian tube around ovulation. Hum Reprod. 1993;8(12):2019–26.
Gould JE, Overstreet JW, Hanson FW. Assessment of human sperm function after recovery from the female reproductive tract. Biol Reprod. 1984;31(5):888–94.
Banna M. Craniopharyngioma: based on 160 cases*. Br J Radiol. 1976;49(579):206–23.
Sklar CA. Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg. 1994;21(Suppl. 1):18–20.
Schlechte J, Sherman B, Halmi N, VanGilder JO, Chapler F, Dolan K, et al. Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study*. Endocr Rev. 1980;1(3):295–308.
Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A, et al. Macroprolactinemia revisited: a study on 106 patients. The Journal of Clinical Endocrinology & Metabolism. 2002;87(2):581–8.
Smith G, Roberts R, Hall C, Nuki G. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Rheumatology. 1996;35(5):458–62.
Zanagnolo V, Dharmarajan AM, Endo K, Wallach EE. Effects of acetylsalicylic acid (aspirin) and naproxen sodium (naproxen) on ovulation, prostaglandin, and progesterone production in the rabbit. Fertil Steril. 1996;65(5):1036–43.
Freda PU, Wardlaw SL, Post KD. Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series. J Clin Endocrinol Metab. 1996;81(10):3455–9.
Frisch RE. The right weight: Body fat, menarche and ovulation. Baillieres Clin Obstet Gynaecol. 1990;4(3):419–39.
Miller JW, Crapo L. The medical treatment of Cushing’s syndrome. Endocr Rev. 1993;14(4):443–58.
Asrm.org.ASRM Patient Booklet: Hirsutism and Polycystic Ovary Syndrome (PCOS) [Internet].2016 [cited 23 February 2016]. Available from: ► https://www.asrm.org/booklet_Hirsutism_and_Polycystic_Ovary_Syndrome_PCOS.
Tuteja N, Saluja S, Jain S, Yadav A, Agarwal LD, Hooja N. Congenital idiopathic isolated clitoromegaly. Int J Basic Appl Med Sci. 2014;4(2):192–4.
Bern HA. In: Herbst AL, editor. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme-Stratton; 1981.
Practice Committee of the American Society for Reproductive Medicine. Vaccination guidelines for female infertility patients: a committee opinion. Fertil Steril. 2013;99(2):337–9.
Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S, Nicoloff J. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem. 1987;33(8):1391–6.
Van den Boogaard E, Vissenberg R, Land JA, van Wely M, van der Post JA, Goddijn M, Bisschop PH. Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011;17(5):605–19.
Jacobs LS, Snyder PJ, Wilber JF, Utiger RD, Daughaday WH. Increased serum prolactin after administration of synthetic thyrotropin-releasing hormone (TRH) in man 1. J Clin Endocrinol Metab. 1971;33(6):996–8.
Luciano AA, Peluso J, Koch EI, Maier D, Kuslis S, Davison E. Temporal relationship and reliability of the clinical, hormonal, and ultrasonographic indices of ovulation in infertile women. Obstet Gynecol. 1990;75(3):412–6.
Organization H. of Research SP. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17β, luteinizing hormone, follicle-stimulating hormone, and progesterone: I. Probit analysis. Am J Obstet Gynecol. 1980;138(4):383–90.
Wathen NC, Perry L, Lilford RJ, Chard T. Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed). 1984;288(6410):7–9.
Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Obstet Gynecol Surv. 1950;5(4):561–4.
Martinez AR, Bernardus RE, Vermeiden JP, Schoemaker J. Time schedules of intrauterine insemination after urinary luteinizing hormone surge detection and pregnancy results. Gynecol Endocrinol. 1994;8(1):1–5.
Scott Jr RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril. 1995;63(1):1–1.
Evers JL, Slaats P, Land JA, Dumoulin JC, Dunselman GA. Elevated levels of basal estradiol-17β predict poor response in patients with normal basal levels of follicle-stimulating hormone undergoing in vitro fertilization. Fertil Steril. 1998;69(6):1010–4.
Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B. Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod. 1996;11(3):486–9.
Navot D, Rosenwaks Z, Margalioth E. Prognostic assessment of female fecundity. Lancet. 1987;330(8560):645–7.
Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22(7):1837–40.
La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006;21(12):3103–7.
Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG Int J Obstet Gynaecol. 2005;112(10):1384–90.
Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21(8):2022–6.
Hendriks DJ, Mol BW, Bancsi LF, te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril. 2005;83(2):291–301.
Fleischer AC. Sonography in gynecology and obstetrics: just the facts. Singapore: McGraw Hill Professional; 2004.
Timor-Tritsch IE, Rottem S, editors. Transvaginal sonography. 2nd ed. New York: Elsevier; 1991.
Hurd WW, Wyckoff ET, Reynolds DB, Amesse LS, Gruber JS, Horowitz GM. Patient rotation and resolution of unilateral cornual obstruction during hysterosalpingography. Obstet Gynecol. 2003;101(6):1275–8.
Hurd WW, Falcone T, editors. Clinical reproductive medicine and surgery. St. Louis, MO: Mosby/Elsevier; 2007.
Mohiyiddeen L, Hardiman A, Fitzgerald C, Hughes E, Mol BW, Johnson N, Watson A. Tubal flushing for subfertility. Cochrane Database Syst Rev. 2015;5
Goldman MB, Thornton KL, Ryley D, Alper MM, Fung JL, Hornstein MD, Reindollar RH. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil Steril. 2014;101(6):1574–81.
Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119–29.
Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson P, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med. 2015;373(13):1230–40.
Reproductivefacts.org. ASRM Patient Fact Sheet: Side effects of injectable fertility drugs (gonadotropins) [Internet]. 2016 [cited 24 February 2016]. Available from: ► http://www.reproductivefacts.org/awards/detail.aspx?id=10209.
Asrm.org. ASRM Patient Fact Sheet: Intrauterine Insemination (IUI) [Internet]. 2016 [cited 23 February 2016]. Available from: ► https://www.asrm.org/awards/detail.aspx?id=8576
MD R. IVF Blastocyst Pictures & Blastocyst Stage Embryo Grading Photos [Internet]. Advancedfertility.com. 2016 [cited 23 February 2016]. Available from: ► http://www.advancedfertility.com/blastocystimages.htm
Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009;360(3):236–43.
Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained subfertility. status and date: new search for studies and content updated (no change to conclusions)., published in. 2015(11) (2015).
Mahlstedt PP, Greenfeld DA. Assisted reproductive technology with donor gametes: the need for patient preparation. Fertil Steril. 1989;52(6):908–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Yu, H.Y., Vrees, R., Frishman, G.N. (2017). Female Infertility. In: Falcone, T., Hurd, W. (eds) Clinical Reproductive Medicine and Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-52210-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-52210-4_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52209-8
Online ISBN: 978-3-319-52210-4
eBook Packages: MedicineMedicine (R0)